|
FANCG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69864122767649E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.36557432028894E-14 |
| Normal-vs-Stage2 |
1.006350E-04 |
| Normal-vs-Stage3 |
1.63109999951061E-07 |
| Normal-vs-Stage4 |
5.50790000053425E-07 |
| Stage1-vs-Stage2 |
6.664400E-02 |
| Stage1-vs-Stage3 |
9.225800E-02 |
| Stage1-vs-Stage4 |
2.340200E-01 |
| Stage2-vs-Stage3 |
6.489800E-01 |
| Stage2-vs-Stage4 |
3.068000E-02 |
| Stage3-vs-Stage4 |
5.128100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68975944347949E-12 |
| Normal-vs-AfricanAmerican |
1.93725999999561E-05 |
| Normal-vs-Asian |
2.233600E-02 |
| Caucasian-vs-AfricanAmerican |
9.266000E-01 |
| Caucasian-vs-Asian |
7.853800E-02 |
| AfricanAmerican-vs-Asian |
1.021440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97875049678942E-12 |
| Normal-vs-Female |
1.37245770304162E-12 |
| Male-vs-Female |
9.972400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.595800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.61408689034215E-13 |
| Normal-vs-Age(61-80Yrs) |
4.69824179560874E-12 |
| Normal-vs-Age(81-100Yrs) |
3.584800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.782000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.563200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.183000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.580000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.014200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.715600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.323660E-03 |
| Normal-vs-Grade 2 |
1.78190795452338E-13 |
| Normal-vs-Grade 3 |
8.84803341705265E-12 |
| Normal-vs-Grade 4 |
1.764900E-04 |
| Grade 1-vs-Grade 2 |
1.799210E-01 |
| Grade 1-vs-Grade 3 |
2.321000E-01 |
| Grade 1-vs-Grade 4 |
5.156800E-01 |
| Grade 2-vs-Grade 3 |
8.668200E-01 |
| Grade 2-vs-Grade 4 |
6.485200E-01 |
| Grade 3-vs-Grade 4 |
6.056200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63069557856943E-12 |
| Normal-vs-ccB subtype |
7.4854999998486E-07 |
| ccA subtype-vs-ccB subtype |
3.135800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26509913656037E-11 |
| Normal-vs-N1 |
3.697500E-03 |
| N0-vs-N1 |
2.136600E-01 |
|
|
